Related references
Note: Only part of the references are listed.Clinical Review on the Management of Metastatic Renal Cell Carcinoma
Jennifer Tran et al.
JCO ONCOLOGY PRACTICE (2022)
Haplotype-resolved assembly of diploid genomes without parental data
Haoyu Cheng et al.
NATURE BIOTECHNOLOGY (2022)
The complete sequence of a human genome
Sergey Nurk et al.
SCIENCE (2022)
The Differential Diagnosis of Medullary-Based Renal Masses
Nicholas Baniak et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
Renal cell carcinoma in children and adolescents
Min He et al.
MEDICINE (2021)
Progress Update in Pediatric Renal Tumors
Juhi Jain et al.
CURRENT ONCOLOGY REPORTS (2021)
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
Christian Thomas et al.
GENES CHROMOSOMES & CANCER (2021)
ALK-rearranged Renal Cell Carcinoma (RCC): A Report of 2 Cases and Review of the Literature Emphasizing the Distinction Between VCL-ALK and Non-VCL-ALK RCC
Sintawat Wangsiricharoen et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2021)
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Daniel D. Shapiro et al.
CANCERS (2021)
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma
Gennady Bratslavsky et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Childhood Clear Cell Sarcoma of Kidney: Incidence and Survival
Hui Gao et al.
FRONTIERS IN PEDIATRICS (2021)
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J. Wiele et al.
CANCERS (2021)
Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib
Alex Q. Lee et al.
FRONTIERS IN ONCOLOGY (2021)
Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series
Alixandra Ryan et al.
CLINICAL GENITOURINARY CANCER (2021)
Haplotype-resolved germline and somatic alterations in renal medullary carcinomas
Kar-Tong Tan et al.
GENOME MEDICINE (2021)
Case Analysis of 14 Children with Malignant Rhabdoid Tumor of the Kidney
Jing Li et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
Pierangela Sepe et al.
CANCERS (2021)
Renal medullary carcinoma masquerading as renal infection: a case report
Zhong-Ming Huang et al.
BMC NEPHROLOGY (2020)
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel et al.
CANCER CELL (2020)
Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments
Darmood Wei et al.
GENES CHROMOSOMES & CANCER (2020)
Renal Medullary Carcinoma on Dual-Time Point FDG PET/CT Imaging
Guozhu Hou et al.
CLINICAL NUCLEAR MEDICINE (2020)
Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
Pavlos Msaouel et al.
MOLECULAR & CELLULAR ONCOLOGY (2020)
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma
Pavlos Msaouel et al.
CLINICAL GENITOURINARY CANCER (2019)
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo et al.
CANCER CELL (2019)
Resolving the full spectrum of human genome variation using Linked-Reads
Patrick Marks et al.
GENOME RESEARCH (2019)
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases
Liwei Jia et al.
MODERN PATHOLOGY (2019)
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
Andrew L. Hong et al.
ELIFE (2019)
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
Amaury Leruste et al.
CANCER CELL (2019)
Renal Medullary Carcinoma: a Report of the Current Literature
Leandro Blas et al.
CURRENT UROLOGY REPORTS (2019)
Atypical presentation of renal medullary carcinoma: A case report and review of the literature
Ali AL-Daghmin et al.
UROLOGY CASE REPORTS (2019)
Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
Christine Bookhout et al.
NEUROPATHOLOGY (2018)
SMARCB1-deficient Tumors of Childhood: A Practical Guide
Bruce R. Pawel
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2018)
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma
Pavlos Msaouel et al.
CLINICAL CANCER RESEARCH (2018)
Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma
David J. Breen et al.
RADIOLOGY (2018)
Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition
Yamila Goenaga-Vazquez et al.
CEN CASE REPORTS (2018)
Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review
Wenjuan Yu et al.
HISTOPATHOLOGY (2017)
Renal medullary carcinoma: A national analysis of 159 patients
Brian Ezekian et al.
PEDIATRIC BLOOD & CANCER (2017)
Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition
Quaovi Sodji et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
Kathryn E. Beckermann et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Renal Medullary Carcinoma: Establishing Standards in Practice
Kathryn E. Beckermann et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes
Maria I. Carlo et al.
CLINICAL GENITOURINARY CANCER (2017)
Renal medullary carcinoma with an ophthalmic metastasis
Christine Ibilibor et al.
UROLOGY ANNALS (2017)
Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas
An Na Seo et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Renal cell cancer histological subtype distribution differs by race and sex
Loren Lipworth et al.
BJU INTERNATIONAL (2016)
Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases
Zhenshan Shi et al.
ONCOLOGY LETTERS (2016)
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
Julien Calderaro et al.
EUROPEAN UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
ALK-rearranged renal cell carcinomas in children
Mariana M. Cajaiba et al.
GENES CHROMOSOMES & CANCER (2016)
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Martin H. Voss et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing
Grace X. Y. Zheng et al.
NATURE BIOTECHNOLOGY (2016)
Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background
Koraljka Gall Troselj et al.
CLINICAL EPIGENETICS (2016)
Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression
Jacob S. Lipkin et al.
CANCER BIOLOGY & THERAPY (2015)
Collecting Duct Carcinoma Versus Renal Medullary Carcinoma An Appeal for Nosologic and Biological Clarity
Mahul B. Amin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
A rationale to target the SWI/SNF complex for cancer therapy
Anja F. Hohmann et al.
TRENDS IN GENETICS (2014)
Renal Medullary Carcinoma Molecular, Immunohistochemistry, and Morphologic Correlation
Qingyan Liu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)
Arnoud J. Templeton et al.
EUROPEAN UROLOGY (2013)
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Sarah K. Knutson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil
Marina Cavalcanti Maroja Silvino et al.
RARE TUMORS (2013)
Carcinoma of the Collecting Ducts of Bellini and Renal Medullary Carcinoma Clinicopathologic Analysis of 52 Cases of Rare Aggressive Subtypes of Renal Cell Carcinoma With a Focus on Their Interrelationship
Ruta Gupta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
SMARCB1/INI1 inactivation in renal medullary carcinoma
Julien Calderaro et al.
HISTOPATHOLOGY (2012)
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Ryan S. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Renal Medullary Carcinoma Metastatic to the Scalp
Ryan P. Johnson et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)
INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics
Travis J. Hollmann et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2011)
ALK Rearrangement in Sickle Cell Trait-Associated Renal Medullary Carcinoma
Adrian Marino-Enriquez et al.
GENES CHROMOSOMES & CANCER (2011)
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes
Zoran Gatalica et al.
HUMAN PATHOLOGY (2011)
Immunohistochemical Analysis of SMARCB1/INI-1 Expression in Collecting Duct Carcinoma
Hillary Elwood et al.
UROLOGY (2011)
Response to radiation in renal medullary carcinoma
Alexandra M. Walsh et al.
RARE TUMORS (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy
Edward M. Schaeffer et al.
BJU INTERNATIONAL (2010)
Complete Response to Carboplatin, Gemcitabine, and Paclitaxel in a Patient With Advanced Metastatic Renal Medullary Carcinoma
Alexandra Walsh et al.
PEDIATRIC BLOOD & CANCER (2010)
Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy
Roula Albadine et al.
JOURNAL OF UROLOGY (2009)
Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior
Jason X. Cheng et al.
MODERN PATHOLOGY (2008)
High-dose-intensity MVAC for advanced renal medullary carcinoma: Report of three cases and literature review
W. Kimryn Rathmell et al.
UROLOGY (2008)
The National Wilms Tumor Study: a 40 year perspective
Giulio J. D'Angio
LIFETIME DATA ANALYSIS (2007)
Renal medullary carcinoma: report of seven cases from Brazil
Isabela C. Watanabe et al.
MODERN PATHOLOGY (2007)
Significant responses to platinum-based chemotherapy in renal medullary carcinoma
JJ Strouse et al.
PEDIATRIC BLOOD & CANCER (2005)
Renal medullary carcinoma metastatic to the orbit: A clinicopathologic report
LA Zdinak et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2004)
Share Paper
